|
|
|
Insider
Information: |
Frost Gregory Ian |
Relationship: |
SVP--Health Sector |
City: |
San Diego, |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
3,941,380 |
|
Indirect Shares
|
190,072 |
|
|
Direct
Value |
$166,023,962 |
|
|
Indirect Value
|
$8,644,475 |
|
|
Total
Shares |
4,131,452 |
|
|
Total
Value |
$174,668,437 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Halozyme Therapeutics Inc |
HALO |
CEO, President, Director |
2013-12-11 |
3,641,380 |
2004-03-11 |
190,072 |
Premium* |
|
Precigen Inc |
PGEN |
SVP--Health Sector |
2015-05-28 |
300,000 |
2014-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-10-25 |
4 |
OE |
$0.43 |
$6,774 |
D/D |
15,754 |
3,085,360 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-09 |
4 |
OE |
$0.43 |
$18,206 |
D/D |
42,340 |
3,111,946 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-20 |
4 |
OE |
$0.43 |
$5,321 |
D/D |
12,374 |
3,121,980 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-21 |
4 |
OE |
$0.43 |
$4,559 |
D/D |
10,603 |
3,120,209 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-12-11 |
4 |
OE |
$0.43 |
$18,387 |
D/D |
42,760 |
3,152,366 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-12-20 |
4 |
OE |
$0.43 |
$4,186 |
D/D |
9,736 |
3,159,342 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2008-03-19 |
4 |
OE |
$0.43 |
$275,158 |
D/D |
639,902 |
3,789,508 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2004-08-18 |
4 |
B |
$1.65 |
$8,250 |
D/D |
5,000 |
2,958,779 |
2.81 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2005-08-23 |
4 |
B |
$1.69 |
$8,450 |
D/D |
5,000 |
3,063,779 |
2.81 |
- |
|
HALO |
Halozyme Therapeutics Inc |
CEO, President |
|
2013-12-11 |
4 |
OE |
$2.02 |
$101,993 |
D/D |
50,000 |
3,641,380 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
CEO, President |
|
2013-08-12 |
4 |
OE |
$2.05 |
$41,000 |
D/D |
20,000 |
3,591,380 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2006-11-30 |
5 |
GD |
$2.89 |
$115,597 |
D/D |
39,999 |
3,023,780 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
CEO, President |
|
2012-08-13 |
4 |
B |
$5.50 |
$11,000 |
D/D |
2,000 |
3,555,331 |
2.81 |
- |
|
HALO |
Halozyme Therapeutics Inc |
CEO, President |
|
2011-08-09 |
4 |
B |
$5.84 |
$35,040 |
D/D |
6,000 |
3,536,866 |
2.81 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2008-03-19 |
4 |
D |
$6.06 |
$173,571 |
D/D |
(28,642) |
3,760,866 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2008-03-20 |
4 |
S |
$6.06 |
$1,393,800 |
D/D |
(230,000) |
3,530,866 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-12-11 |
4 |
D |
$6.66 |
$18,382 |
D/D |
(2,760) |
3,149,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-12-20 |
4 |
D |
$6.98 |
$4,181 |
D/D |
(599) |
3,158,743 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-12-20 |
4 |
AS |
$7.00 |
$63,959 |
D/D |
(9,137) |
3,149,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-21 |
4 |
AS |
$7.51 |
$76,246 |
D/D |
(10,000) |
3,109,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-21 |
4 |
D |
$7.56 |
$4,559 |
D/D |
(603) |
3,119,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-20 |
4 |
AS |
$7.57 |
$76,803 |
D/D |
(9,800) |
3,111,506 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-09 |
4 |
D |
$7.78 |
$18,205 |
D/D |
(2,340) |
3,109,606 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-11-20 |
4 |
D |
$7.87 |
$5,304 |
D/D |
(674) |
3,121,306 |
0 |
- |
|
HALO |
Halozyme Therapeutics Inc |
VP and Chief Scientific Off. |
|
2007-08-02 |
4 |
AS |
$7.89 |
$29,467 |
D/D |
(3,700) |
2,980,906 |
0 |
- |
|
87 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|